JP2015508051A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015508051A5 JP2015508051A5 JP2014538946A JP2014538946A JP2015508051A5 JP 2015508051 A5 JP2015508051 A5 JP 2015508051A5 JP 2014538946 A JP2014538946 A JP 2014538946A JP 2014538946 A JP2014538946 A JP 2014538946A JP 2015508051 A5 JP2015508051 A5 JP 2015508051A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261602888P | 2012-02-24 | 2012-02-24 | |
| US61/602,888 | 2012-02-24 | ||
| PCT/JP2013/055605 WO2013125732A1 (en) | 2012-02-24 | 2013-02-22 | Aromatic ring compound |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015508051A JP2015508051A (ja) | 2015-03-16 |
| JP2015508051A5 true JP2015508051A5 (enExample) | 2016-04-07 |
| JP6106179B2 JP6106179B2 (ja) | 2017-03-29 |
Family
ID=47891826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014538946A Active JP6106179B2 (ja) | 2012-02-24 | 2013-02-22 | 芳香環化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9238639B2 (enExample) |
| EP (1) | EP2838891B1 (enExample) |
| JP (1) | JP6106179B2 (enExample) |
| CN (1) | CN104254525B (enExample) |
| CA (1) | CA2864990C (enExample) |
| ES (1) | ES2640258T3 (enExample) |
| WO (1) | WO2013125732A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3193939A4 (en) * | 2014-09-17 | 2018-10-24 | The Regents of The University of California | Small lipopeptidomimetic inhibitors of ghrelin o-acyl transferase |
| AR104673A1 (es) * | 2015-04-15 | 2017-08-09 | Lilly Co Eli | Inhibidores de grelina o-aciltransferasa |
| AR104672A1 (es) * | 2015-04-15 | 2017-08-09 | Lilly Co Eli | Inhibidores de grelina o-aciltransferasa |
| CN105566263A (zh) * | 2016-01-27 | 2016-05-11 | 中国药科大学 | 一类新型含氮杂环衍生物、其制备方法及其作为药物的用途 |
| DK3494120T3 (da) * | 2016-08-05 | 2021-05-31 | Boehringer Ingelheim Int | Oxadiazolopyridinderivater til anvendelse som ghrelin-o-acyl-transferase-(goat)-inhibitorer |
| TW201831471A (zh) * | 2017-02-24 | 2018-09-01 | 盧森堡商艾伯維公司 | 囊腫纖化症跨膜傳導調節蛋白的調節劑及其使用方法 |
| US10394034B2 (en) * | 2017-08-15 | 2019-08-27 | Microsoft Technology Licensing, Llc | Eye-tracking with MEMS scanning and optical relay |
| DK3737470T5 (da) | 2018-01-08 | 2024-05-27 | Celon Pharma Sa | 3-phenyl-4-hexynsyrederivater som gpr40-agonister |
| EP3746449B1 (en) * | 2018-02-02 | 2022-03-30 | Boehringer Ingelheim International GmbH | Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors |
| CA3087827A1 (en) | 2018-02-02 | 2019-08-08 | Boehringer Ingelheim International Gmbh | Heterocyclyl-substituted oxadiazolopyridine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors |
| JOP20200190A1 (ar) | 2018-02-02 | 2020-07-29 | Boehringer Ingelheim Int | مشتقات أوكسادايازولو بيريدين بها استبدال ببنزيل -، (بيريدين -3- يل) ميثيل - أو (بيريدين -4- يل) ميثيل كمثبطات جريلين o- أسيل ترانسفيراز (goat) |
| JOP20200187A1 (ar) | 2018-02-02 | 2020-07-29 | Boehringer Ingelheim Int | مشتقات ترايازولو بيريميدين للاستخدام كمثبطات جريلين o- أسيل ترانسفيراز (goat) |
| US11312709B2 (en) * | 2018-02-05 | 2022-04-26 | Glaxosmithkline Intellectual Property Development Limited | Ghrelin O-acyltransferase inhibitors |
| CN108516972A (zh) * | 2018-05-30 | 2018-09-11 | 王丽萍 | 一种goat抑制剂及其在肥胖和糖尿病中的应用 |
| CN108558849A (zh) * | 2018-05-30 | 2018-09-21 | 王丽萍 | 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用 |
| CN108774221A (zh) * | 2018-05-30 | 2018-11-09 | 王丽萍 | 一种goat抑制剂及其在肥胖和糖尿病中的应用 |
| CN108610337A (zh) * | 2018-05-30 | 2018-10-02 | 王丽萍 | 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用 |
| CN108558852A (zh) * | 2018-05-30 | 2018-09-21 | 王丽萍 | 一种goat抑制剂及其在肥胖和糖尿病中的应用 |
| CN108516971A (zh) * | 2018-05-30 | 2018-09-11 | 王丽萍 | 一种苯并[b]噻吩类化合物及其在肥胖和糖尿病中的应用 |
| CN115667277A (zh) | 2020-02-28 | 2023-01-31 | 卡尔优普公司 | Gpr40激动剂 |
| JP7702969B2 (ja) | 2020-05-22 | 2025-07-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アルキル７－アミノ－５－メチル－［１，２，５］オキサジアゾロ［３，４－ｂ］ピリジンカルボキシレートの連続製造方法 |
| CN115884974B (zh) | 2020-05-22 | 2024-09-17 | 勃林格殷格翰国际有限公司 | 制备烷基7-氨基-5-甲基-[1,2,5]噁二唑并[3,4-b]吡啶羧酸酯的方法 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA945085B (en) * | 1993-07-14 | 1995-02-22 | Smithkline Beecham Corp | 5-Lipoxygenase inhibitors |
| CN1072649C (zh) | 1995-09-13 | 2001-10-10 | 武田药品工业株式会社 | 苯并氧杂吖庚因化合物,其生产方法和用途 |
| GB2350111A (en) * | 1999-05-17 | 2000-11-22 | Bayer Ag | Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives |
| AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
| AU2001252596A1 (en) | 2000-04-28 | 2001-11-12 | Takeda Chemical Industries Ltd. | Melanin concentrating hormone antagonists |
| WO2001087834A1 (en) | 2000-05-16 | 2001-11-22 | Takeda Chemical Industries, Ltd. | Melanin-concentrating hormone antagonist |
| AU2001269531A1 (en) | 2000-07-17 | 2002-01-30 | Takeda Chemical Industries Ltd. | Sulfone derivatives, process for their production and use thereof |
| US6867224B2 (en) * | 2002-03-07 | 2005-03-15 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods of preparation |
| CN1731994A (zh) | 2002-11-01 | 2006-02-08 | 武田药品工业株式会社 | 预防或治疗神经病的药剂 |
| AU2003277576A1 (en) | 2002-11-08 | 2004-06-07 | Takeda Pharmaceutical Company Limited | Receptor function controlling agent |
| WO2004048363A1 (ja) | 2002-11-22 | 2004-06-10 | Takeda Pharmaceutical Company Limited | イミダゾール誘導体、その製造法および用途 |
| EP1581521A1 (en) * | 2003-01-06 | 2005-10-05 | Eli Lilly And Company | Fused heterocyclic derivatives as ppar modulators |
| US7244763B2 (en) | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
| CA2527691C (en) * | 2003-05-30 | 2013-01-22 | Takeda Pharmaceutical Company Limited | Condensed ring compound |
| EP1669352A4 (en) | 2003-09-30 | 2008-12-17 | Takeda Pharmaceutical | THIAZOLINE DERIVATIVE AND ITS USE |
| US7820673B2 (en) | 2003-12-17 | 2010-10-26 | Takeda Pharmaceutical Company Limited | Urea derivative, process for producing the same, and use |
| AU2004309271A1 (en) | 2003-12-25 | 2005-07-14 | Takeda Pharmaceutical Company Limited | 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| US7585880B2 (en) | 2003-12-26 | 2009-09-08 | Takeda Pharmaceutical Company Limited | Phenylpropanoic acid derivatives |
| US7786165B2 (en) | 2004-03-15 | 2010-08-31 | Takeda Pharmaceutical Company Limited | Aminophenylpropanoic acid derivative |
| EP2253315A1 (en) | 2004-03-30 | 2010-11-24 | Takeda Pharmaceutical Company Limited | Alkoxyphenylpropanoic acid derivatives |
| TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
| US20060014785A1 (en) | 2004-05-25 | 2006-01-19 | Metabolex, Inc. | Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation |
| EP2308839B1 (en) | 2005-04-20 | 2017-03-01 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compounds |
| JP5084503B2 (ja) | 2005-07-29 | 2012-11-28 | 武田薬品工業株式会社 | シクロプロパンカルボン酸化合物 |
| WO2007013694A1 (ja) | 2005-07-29 | 2007-02-01 | Takeda Pharmaceutical Company Limited | フェノキシアルカン酸化合物 |
| JP4094660B1 (ja) | 2005-08-10 | 2008-06-04 | 武田薬品工業株式会社 | 糖尿病治療剤 |
| JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| WO2007092751A2 (en) | 2006-02-03 | 2007-08-16 | Eli Lilly And Company | Compounds and methods for modulating fx-receptors |
| RU2444521C2 (ru) * | 2006-06-27 | 2012-03-10 | Такеда Фармасьютикал Компани Лимитед | Конденсированные циклические соединения |
| US8492405B2 (en) | 2006-10-18 | 2013-07-23 | Takeda Pharmaceutical Company Limited | Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity |
| MX2009003972A (es) | 2006-10-19 | 2009-04-27 | Takeda Pharmaceutical | Compuesto de indol. |
| EP2128138A1 (en) | 2007-01-29 | 2009-12-02 | Takeda Pharmaceutical Company Limited | Pyrazole compound |
| EA200970746A1 (ru) | 2007-02-09 | 2010-02-26 | Такеда Фармасьютикал Компани Лимитед | Конденсированные циклические соединения в качестве частичных агонистов ppar-гамма |
| JPWO2008136428A1 (ja) | 2007-04-27 | 2010-07-29 | 武田薬品工業株式会社 | 含窒素５員複素環化合物 |
| US20110301155A1 (en) | 2007-06-19 | 2011-12-08 | Tsuneo Yasuma | Indazole compounds for activating glucokinase |
| WO2009137500A1 (en) | 2008-05-05 | 2009-11-12 | Wyeth | 6-substituted benzofuran compounds to treat infection with hepatitis c virus |
| JP5535931B2 (ja) * | 2008-10-27 | 2014-07-02 | 武田薬品工業株式会社 | 二環性化合物 |
| JP5657578B2 (ja) * | 2009-06-09 | 2015-01-21 | 武田薬品工業株式会社 | 新規な縮合環化合物およびその用途 |
-
2013
- 2013-02-22 CA CA2864990A patent/CA2864990C/en active Active
- 2013-02-22 US US14/380,215 patent/US9238639B2/en active Active
- 2013-02-22 WO PCT/JP2013/055605 patent/WO2013125732A1/en not_active Ceased
- 2013-02-22 JP JP2014538946A patent/JP6106179B2/ja active Active
- 2013-02-22 CN CN201380021676.2A patent/CN104254525B/zh active Active
- 2013-02-22 EP EP13710076.4A patent/EP2838891B1/en active Active
- 2013-02-22 ES ES13710076.4T patent/ES2640258T3/es active Active